Alpha Modus Holdings, Inc. (NASDAQ:AMOD), a company specializing in patent ownership and leasing, received a notice from the Nasdaq Stock Market on Monday, indicating that it no longer meets the ...

Disclaimer: The analyst who wrote this piece owns shares of Strategy (MSTR).Strategy (MSTR) expects its convertible preferred ...

IN8bio, Inc. (NASDAQ:INAB), a biotechnology firm specializing in cancer therapies, has been granted an additional 180 days to comply with Nasdaq's minimum bid price rule, as per a recent SEC filing.

BioAtla, Inc., a biotechnology firm specializing in biological products, received notice from The Nasdaq Stock Market on Tuesday that it is at risk of being delisted. Currently trading at $0.45, the ...

ECD Automotive Design, Inc., a Delaware-based company specializing in motor vehicles and passenger car bodies, has been notified by The Nasdaq Stock Market LLC of non-compliance with the exchange's ...

SAN ANTONIO, TX - bioAffinity Technologies, Inc. has been notified by The Nasdaq Stock Market LLC that it has not met the minimum bid price requirement for continued listing on The Nasdaq Capital ...

DUBLIN - Brera Holdings PLC (NASDAQ:BREA), an international holding company currently valued at $8.27 million, has been notified by the Nasdaq that it has not complied with the annual meeting ...

Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...

Evergreen Corporation, a company specializing in blank check investments under the organization name "05 Real Estate & Construction," has been notified by Nasdaq of its non-compliance with the minimum ...

As a result, the Company’s shares will remain listed on the Nasdaq Capital Market. In addition, as it relates to Listing Rule 5550(a)(2) (the “Bid Price Rule”), the Staff has determined that ...

Hotel101 Global—a unit of DoubleDragon, which is jointly owned by Philippine fast food giant Jollibee founder Tony Tan ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...